Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Tests a heart procedure called ischemic postconditioning in heart attack patients

Tests ischemic postconditioning, a brief blood-flow procedure, in adults having a STEMI heart attack.

Plain-language title generated from the registry record
Registry title: Ischemic Postconditioning in STEMI Patients Treated With Primary PCI

Key facts

Where
Copenhagen, DenmarkSee the site

Where in Denmark

  • The Heart Center, Rigshospitalet, University of CopenhagenCopenhagen, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Copenhagen University Hospital, Rigshospitalet
Trial code
NCT03787745
Record updated
30 March 2026
Original description
In a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primary PCIRead full original descriptionShow less

The Effect of Ischemic Postconditioning in Patients With STEMI Undergoing Primary PCI (DANAMI4-iPOST2)

In a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primary PCI

Inclusion: Age ≥18 years; Acute onset of chest pain with < 12 hours duration; STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lead (II, III and aVF, I, aVL) and V4-V6 or ST depression in 2 or more V1 through V4 leads indicating posterior AMI; TIMI flow 0-1 in infarct related artery.

Exclusion: Potential pregnancy; Refusal to participate; OHCA without subsequent consciousness despite ROSC; Thrombectomy considered unavoidable.

ClinicalTrials.gov NCT03787745